Loading clinical trials...
Loading clinical trials...
An Initial Trial of Enteral Fish Oil Supplementation in the Treatment of Parenteral Nutrition-associated Liver Disease in Patients With Short Bowel Syndrome
The purpose of this study is to investigate the usefulness of oral fish oil(Lovaza)in normalizing liver function in patients who have parenteral nutrition associated liver disease. The investigators believe that patients who take oral fish oil will normalize liver function faster than those who do not
This is designed as a randomized placebo controlled trial of oral fish oil (Lovaza) in normalizing parenteral nutrition associated liver disease.
Age
0 - 21 years
Sex
ALL
Healthy Volunteers
No
Children's Hospital Boston
Boston, Massachusetts, United States
Start Date
January 1, 2011
Primary Completion Date
January 1, 2012
Completion Date
January 1, 2012
Last Updated
June 22, 2017
Lovaza (omega-3-acid ethyl ester)
DRUG
Corn oil
DIETARY_SUPPLEMENT
Lead Sponsor
Boston Children's Hospital
Collaborators
NCT07480057
NCT07237750
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06181409